MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

Sledge, George W., Jr.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena; Masuda, Norikazu; Kaufman, Peter A.; Koh, Han; Grischke, Eva-Maria; Frenzel, Martin; Lin, Yong; Barriga, Susana; Smith, Ian C.; Bourayou, Nawel; Llombart-Cussac, Antonio

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2019-05-13T06:19:36Z
dc.date.available	2019-05-13T06:19:36Z
dc.date.issued	2017
dc.identifier.issn	1527-7755
dc.identifier.uri	http://hdl.handle.net/10900/88652
dc.language.iso	en	de_DE
dc.publisher	Amer Soc Clinical Oncology	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.2017.73.7585	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_01489
utue.publikation.seiten	2875-	de_DE
utue.personen.roh	Sledge, George W., Jr.
utue.personen.roh	Toi, Masakazu
utue.personen.roh	Neven, Patrick
utue.personen.roh	Sohn, Joohyuk
utue.personen.roh	Inoue, Kenichi
utue.personen.roh	Pivot, Xavier
utue.personen.roh	Burdaeva, Olga
utue.personen.roh	Okera, Meena
utue.personen.roh	Masuda, Norikazu
utue.personen.roh	Kaufman, Peter A.
utue.personen.roh	Koh, Han
utue.personen.roh	Grischke, Eva-Maria
utue.personen.roh	Frenzel, Martin
utue.personen.roh	Lin, Yong
utue.personen.roh	Barriga, Susana
utue.personen.roh	Smith, Ian C.
utue.personen.roh	Bourayou, Nawel
utue.personen.roh	Llombart-Cussac, Antonio
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	25	de_DE
dcterms.isPartOf.ZS-Volume	35	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE